By apyxmedical In 2018 Shareholder News, J-Plasma, RenuvionPosted February 7, 2019APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS ON MARCH 13, 2019 READ MORE
By apyxmedical In 2018 Shareholder News, J-Plasma, RenuvionPosted January 14, 2019APYX MEDICAL CORPORATION ANNOUNCES THE PROMOTION OF TODD HORNSBY TO EXECUTIVE VICE PRESIDENT READ MORE
By apyxmedical In 2018 Shareholder News, J-Plasma, RenuvionPosted January 7, 2019APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2018 REVENUE RESULTS READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 21, 2018BOVIE MEDICAL CORPORATION FILES 510(K) SUBMISSION WITH THE FDA FOR A NEW INDICATION TO MARKET AND SELL J-PLASMA/RENUVION FOR USE IN DERMAL RESURFACING PROCEDURES READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 17, 2018BOVIE MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF TARA H. SEMB AS CHIEF FINANCIAL OFFICER READ MORE
